EU competition regulators have given the green light to two major joint projects in the European Union, with a focus on the hydrogen and healthcare industries. The first project, worth $1.52 billion, will be funded by seven EU countries - Estonia, France, Germany, Italy, Netherlands, Slovakia, and Spain. This initiative is projected to not only receive public funding but also attract an additional 3.3 billion euros in private investments. Thirteen projects involving 11 companies, including industry giants like Airbus, BMW, and Michelin, will participate in this hydrogen venture. Simultaneously, a $1.1 billion healthcare project, financed by Belgium, France, Hungary, Italy, Slovakia, and Spain, aims to support research and innovation in the healthcare sector. This project is expected to unlock 5.9 billion euros in private investments, with 14 healthcare schemes involving companies such as Sanofi and Euroapi. Both projects have been categorized as Important Projects of Common European Interest (IPCEI), allowing EU governments to provide funding under relaxed state aid rules. These initiatives are pivotal for promoting technological advancement, investment, and collaboration among key industry players, fostering economic growth and innovation in the EU.